Atherectomy Devices Market Size & Share 2026-2035

Atherectomy Devices Market Size

The global atherectomy devices market was valued at USD 866.4 million in 2025. The market is expected to reach USD 941 million in 2026 to USD 1.6 billion in 2035, growing at a CAGR of 6.4% during the forecast period, according to the latest report published by Global Market Insights Inc.

The high market growth is attributed to the increasing prevalence of peripheral artery disease (PAD) and coronary artery disease (CAD); growing ageing populations; sedentary lifestyles; and rising incidences of diabetes and obesity, among other factors.

Atherectomy devices are medical tools used to remove plaque (fatty deposits) from blood vessels. They help improve blood flow in patients suffering from conditions like peripheral artery disease (PAD) and coronary artery disease (CAD). These devices work using different techniques such as cutting, grinding, shaving, or using laser energy to break down and remove the plaque without requiring major surgery.

The major players in the global atherectomy devices market are Abbott, Boston Scientific, Medtronic, Philips, and Becton, Dickinson and Company. These companies maintain their competitive position through ongoing product innovation, global market presence, and substantial investment in research and development.

The market increased from USD 660.4 million in 2022 to USD 794.6 million in 2024, registering a historical growth rate of 9.7%. This growth was primarily driven by advancements in minimally invasive procedures, along with the development of technologically advanced atherectomy devices, such as laser and orbital atherectomy systems, which have improved procedural outcomes and increased adoption rates.

Furthermore, continuous innovations by key manufacturers, including the integration of real-time imaging and artificial intelligence to enhance procedural accuracy, are improving clinical efficacy and patient outcomes. The growing preference for outpatient procedures and ambulatory surgical centers, owing to their cost efficiency and convenience, is also contributing to the increasing demand for atherectomy devices.

Additionally, the rising number of regulatory approvals and clinical trials demonstrating the safety and efficacy of novel atherectomy systems is encouraging broader market adoption. Overall, the combined impact of technological advancements, patient-centric healthcare trends, and demographic shifts continues to support the strong growth trajectory of the atherectomy devices market.

Atherectomy Devices Market Trends

Several trends are shaping the atherectomy devices industry. The growing preference for minimally invasive vascular procedures is significantly driving the adoption of atherectomy devices across both peripheral and coronary interventions. Catheter-based plaque removal techniques offer several advantages, including reduced procedural trauma, shorter hospital stays, faster recovery times, and lower complication risks compared to traditional surgical approaches such as bypass surgery. These benefits are strengthening the role of atherectomy as an important strategy for vessel preparation and plaque modification in modern endovascular treatments.

• Advancements in atherectomy device technologies represent another key trend influencing market evolution. The development of directional, rotational, orbital, and laser atherectomy systems has significantly enhanced procedural precision, safety, and efficiency. These devices enable targeted removal of atherosclerotic plaque while minimizing damage to surrounding healthy vessel tissue. Improvements in catheter design, device flexibility, and plaque removal mechanisms have further strengthened clinical outcomes, especially in complex and heavily calcified lesions, supporting broader physician adoption.
• Additionally, increasing patient awareness and supportive healthcare policies are contributing to market growth. Awareness campaigns highlighting the benefits of minimally invasive treatments, along with favorable reimbursement frameworks in developed regions, are encouraging higher procedure uptake. At the same time, healthcare systems are increasingly focusing on cost-effective, patient-centric care models, which is driving the shift toward minimally invasive vascular interventions. This trend is expected to continue strengthening the role of atherectomy devices in routine clinical practice over the coming years.

Atherectomy Devices Market Analysis

Based on product, the market is segmented into orbital atherectomy devices, laser atherectomy devices, directional atherectomy devices, and rotational atherectomy devices. The orbital atherectomy devices segment has asserted its dominance by securing a significant market share of 30.6% in 2025. The segment is expected to reach USD 495.8 million by 2035, growing at a CAGR of 6.3% during the forecast period.

• The increasing adoption of orbital atherectomy devices is primarily driven by their ability to provide consistent and controlled plaque modification, particularly in heavily calcified lesions. These devices utilize a spinning crown mechanism to safely sand away plaque while preserving arterial wall integrity, making them highly suitable for both peripheral and coronary interventions.
• The rising prevalence of peripheral artery disease (PAD) and coronary artery disease (CAD), especially among aging and diabetic populations, is further supporting segment growth. Orbital atherectomy systems are widely preferred in complex cases due to their effectiveness in treating diffuse and calcified plaques, where conventional balloon angioplasty alone may be insufficient.
• In addition, technological advancements in orbital atherectomy platforms are contributing to increased adoption. Innovations such as enhanced crown designs, improved lubrication techniques, and integration with real-time imaging technologies have significantly improved device precision, safety, and ease of use, thereby enabling better clinical outcomes and reducing complication rates.
• The laser atherectomy devices segment accounted for USD 243.3 million in 2025 and is projected to expand at a CAGR of 6.5% from 2026 to 2035. The segmental growth is driven by the increasing demand for precise and minimally invasive plaque removal techniques. Laser systems utilize light energy to vaporize plaque at a molecular level, making them highly effective for treating complex lesions, including chronic total occlusions and in-stent restenosis. These devices are widely used in both peripheral and coronary applications where controlled plaque ablation is critical.
• The directional atherectomy devices segment accounted for USD 199.5 million in 2025 and is projected to expand at a CAGR of 5.9% from 2026 to 2035. Segment growth is primarily driven by the ability of these devices to selectively target and remove plaque while preserving healthy vessel tissue. These systems are particularly preferred for treating eccentric and calcified lesions, as they allow physicians to precisely cut and collect plaque. Their increasing use in vessel preparation prior to adjunctive therapies, such as drug-coated balloons, is further supporting adoption across peripheral vascular interventions.
• The rotational atherectomy devices segment accounted for USD 158.9 million in 2025 and is projected to expand at a CAGR of 6.9% from 2026 to 2035. Growth in this segment is driven by the effectiveness of rotational atherectomy devices in treating heavily calcified and resistant lesions. These devices utilize high-speed rotating burrs or blades to grind plaque into fine particles, thereby improving vessel compliance and facilitating subsequent procedures such as angioplasty or stenting. Their strong clinical utility in complex PAD cases, along with increasing procedural volumes, is supporting a steady segment.

Based on application, the atherectomy devices market is classified into peripheral vascular applications and coronary applications. The peripheral vascular segment dominated the market with a revenue share of 76.6% in 2025.

• The high and growing prevalence of peripheral artery disease (PAD) is a major factor driving the dominance of the peripheral vascular segment. Factors such as aging populations, increasing incidence of diabetes, smoking, and sedentary lifestyles have significantly increased the global burden of PAD, creating strong demand for effective plaque removal and vessel preparation solutions like atherectomy.
• Atherectomy procedures have become an important part of endovascular treatment protocols for PAD, particularly in complex and heavily calcified lesions where conventional angioplasty alone may be insufficient. These minimally invasive procedures help restore blood flow, improve mobility, and reduce the risk of limb-threatening complications, thereby supporting strong clinical adoption.
• Moreover, advancements in atherectomy technologies, including directional, rotational, and orbital systems, are enhancing procedural precision and safety. The integration of imaging guidance and real-time feedback enables targeted plaque removal, improving clinical outcomes and expanding the suitability of atherectomy for complex vascular cases.
• The coronary applications segment accounted for USD 203.1 million in 2025 and is projected to grow at a CAGR of 6.9% over the forecast period. Growth is primarily driven by the increasing prevalence of coronary artery disease (CAD), particularly among aging populations and patients with diabetes and lifestyle-related risk factors. A significant proportion of these cases involve heavily calcified lesions, where atherectomy devices are used to modify plaque and improve vessel compliance prior to stenting or angioplasty, supporting segment growth.

Based on end use, the market is classified into hospitals, ambulatory surgical centers, and other end users. The hospitals segment dominated the market in 2025 and is expected to reach USD 1 billion through the forecast period.

• Hospitals represent the primary end user segment in the atherectomy devices market, as they are equipped with advanced infrastructure and specialized clinical expertise required to perform complex cardiovascular interventions such as peripheral and coronary atherectomy procedures. The presence of skilled interventional cardiologists, vascular surgeons, and multidisciplinary care teams positions hospitals as the central point of care for managing patients with peripheral artery disease (PAD) and coronary artery disease (CAD).   
• Additionally, hospitals are equipped with state-of-the-art imaging and diagnostic technologies, including fluoroscopy, intravascular ultrasound (IVUS), and other advanced guidance systems, which support precise device navigation and plaque removal. These capabilities enable improved procedural accuracy, enhanced safety, and better patient outcomes, reinforcing the strong adoption of atherectomy devices in hospital settings.
• Furthermore, the high patient volume in hospitals, coupled with the increasing global burden of cardiovascular diseases, continues to drive demand for advanced endovascular interventions. Favorable reimbursement frameworks and insurance coverage for cardiovascular procedures in developed regions also contribute to higher adoption, making atherectomy therapies more accessible to patients.
• The ambulatory surgical centers segment accounted for significant revenue in 2025 and is anticipated to grow at a CAGR of 6.3% over the forecast period. Growth in this segment is driven by the increasing shift of minimally invasive vascular procedures to outpatient settings. ASCs are increasingly adopting atherectomy devices for routine and less complex cases to improve procedural efficiency, reduce hospital burden, and provide cost-effective, same-day discharge care.

North America Atherectomy Devices Market

North America dominated the global atherectomy devices industry with the highest market share of 58.8% in 2025.

• The U.S.  market was valued at USD 369.1 million and USD 403.2 million in 2022 and 2023, respectively. The market size reached USD 475.6 million in 2025, growing from USD 438.8 million in 2024, and is anticipated to grow at a CAGR of 6.4% from 2026 to 2035.
• North America, particularly the U.S., represents a significant market for atherectomy devices, supported by the rising prevalence of cardiovascular diseases such as peripheral artery disease (PAD) and coronary artery disease (CAD). These conditions are widely observed due to factors including aging populations, sedentary lifestyles, and increasing rates of diabetes and obesity, driving strong demand for minimally invasive vascular interventions.
• The region benefits from a well-established healthcare infrastructure and widespread adoption of advanced interventional techniques for cardiovascular care. The availability of skilled interventional cardiologists, vascular surgeons, and advanced catheterization laboratories enables accurate diagnosis and efficient management of complex arterial conditions, reinforcing strong utilization of atherectomy devices across hospital and specialty care settings.
• Furthermore, continuous technological advancements, including the integration of imaging guidance systems, are improving procedural precision and clinical outcomes. The presence of leading atherectomy device manufacturers in the U.S. also ensures ongoing innovation and early adoption of next-generation technologies, positioning North America as a mature and high-value market within the global atherectomy devices landscape.

Europe Atherectomy Devices Market

Europe market accounted for USD 163.4 million in 2025 and is anticipated to show lucrative growth over the forecast period.

• Countries such as Germany, France, and UK are gaining traction in the treatment of complex vascular conditions, particularly among elderly patients requiring less invasive alternatives to surgery. The increasing demand for effective plaque removal in calcified and high-risk lesions is supporting the adoption of advanced atherectomy technologies across cardiovascular care settings.
• Many European countries benefit from well-established healthcare systems with universal or near-universal coverage, ensuring broad patient access to advanced cardiovascular treatments. In the United Kingdom, the National Health Service is increasingly focusing on cost-effective and minimally invasive treatment approaches, thereby encouraging the adoption of atherectomy devices among suitable patient populations. Government support, along with favorable reimbursement structures, is further enabling wider access to these procedures.
• Furthermore, rising public awareness regarding the early diagnosis and treatment of cardiovascular conditions is encouraging patients to opt for minimally invasive procedures. This, combined with ongoing innovations in device design and the increasing availability of specialized vascular care centers, is expected to support the steady growth of the market across Europe over the coming years.

Asia Pacific Atherectomy Devices Market

The Asia Pacific market is anticipated to grow at the highest CAGR of 7.1% during the analysis timeframe.

• Asia Pacific represents a rapidly growing market for atherectomy devices, driven by significant demographic changes and the rising prevalence of cardiovascular diseases across the region. Countries such as China are witnessing a sharp increase in conditions such as peripheral artery disease (PAD) and coronary artery disease (CAD), fueled by aging populations, urbanization, and lifestyle-related risk factors including smoking, unhealthy diets, and obesity. This growing disease burden is substantially increasing the demand for minimally invasive vascular interventions, including atherectomy procedures.
• In countries such as China, atherectomy devices are gaining increased adoption for the management of complex and calcified vascular lesions. The rising need for effective plaque removal techniques, particularly in high-risk and elderly patient populations, is supporting the use of advanced atherectomy technologies across both peripheral and coronary interventions.
• Healthcare systems across the region are undergoing rapid development, supported by significant investments in medical infrastructure and advanced technologies. In China, hospitals are increasingly equipped with modern catheterization laboratories and interventional capabilities, enabling the use of sophisticated atherectomy systems for accurate and efficient treatment of vascular conditions.
• Furthermore, the presence of local manufacturers and collaborations with global medical device companies is enhancing affordability and expanding access to atherectomy technologies. This increasing availability, combined with rising awareness of minimally invasive treatment benefits, is expected to drive sustained growth of the atherectomy devices industry across Asia Pacific in the coming years.

Latin America Atherectomy Devices Market

The Latin America market is experiencing robust growth over the analysis timeframe.

• Latin America represents an emerging market for atherectomy devices, supported by the gradual expansion of private healthcare facilities and specialized cardiovascular centers across the region. Private hospitals in countries such as Brazil, Mexico, and Argentina are increasingly investing in advanced catheterization laboratories and interventional capabilities to manage complex cardiovascular conditions, including peripheral artery disease (PAD) and coronary artery disease (CAD). This expansion of private-sector healthcare infrastructure is driving greater adoption of atherectomy procedures for minimally invasive plaque removal.
• Additionally, ongoing improvements in healthcare access and referral networks are strengthening the diagnosis and treatment of cardiovascular diseases across Latin America. The growing availability of interventional cardiology services in urban hospitals and specialty centers is enabling earlier detection and effective management of arterial blockages using atherectomy devices. Increased physician training and modernization of vascular intervention units are further supporting procedural growth.
• Furthermore, rising awareness of minimally invasive treatment options and gradual increases in healthcare spending by both public and private providers are enhancing the uptake of atherectomy devices in the region. As healthcare systems continue to modernize and emphasize improved patient outcomes and reduced procedural complications, the use of atherectomy devices is expected to increase steadily across Latin America over the forecast period.

Middle East & Africa Atherectomy Devices Market

The Middle East & Africa (MEA) market is experiencing robust growth over the analysis timeframe.

• The Middle East & Africa (MEA) represents a developing market for atherectomy devices, driven by the rising prevalence of lifestyle‑ and age‑related cardiovascular conditions that increase the risk of peripheral artery disease (PAD) and coronary artery disease (CAD). Factors such as obesity, diabetes, and metabolic disorders, particularly prevalent in Middle Eastern countries, are contributing to a higher incidence of vascular blockages and calcified lesions, thereby increasing the demand for minimally invasive interventions such as atherectomy procedures.
• Countries in the Gulf Cooperation Council (GCC) are making substantial investments in healthcare infrastructure, including the development of advanced hospitals, tertiary care centers, and specialized cardiovascular facilities. These investments are improving access to modern diagnostic tools and interventional technologies, enabling more effective management of complex vascular diseases and supporting the growing adoption of atherectomy devices across the region.
• Furthermore, the shift toward minimally invasive treatment approaches, supported by government healthcare initiatives and rising medical investments, is enhancing the uptake of advanced vascular therapies. As healthcare systems continue to evolve and focus on improving clinical outcomes, the utilization of atherectomy devices is expected to increase steadily across the Middle East & Africa over the forecast period.

Atherectomy Devices Market Share

The global atherectomy devices industry is characterized by moderate to high competition, driven by continuous technological innovation, strong clinical demand for minimally invasive vascular procedures, and increasing emphasis on improving treatment outcomes for peripheral and coronary artery diseases. Manufacturers are actively focusing on developing advanced atherectomy systems with enhanced precision, improved plaque removal efficiency, reduced procedural complications, and better integration with imaging technologies for real-time guidance.

Key players in the market include Abbott, Boston Scientific, Medtronic, Philips, and Becton, Dickinson and Company, which collectively account for a substantial share of the global market. These companies benefit from strong global distribution networks, established relationships with hospitals and interventional specialists, and a broad portfolio of atherectomy technologies, including orbital, rotational, directional, and laser systems. Significant investments in research and development enable continuous product innovation, with a focus on improving device safety, ease of use, and effectiveness in treating complex and heavily calcified vascular lesions.

In addition to major multinational companies, several emerging and niche players contribute to market competition by offering differentiated technologies, including image-guided atherectomy and next-generation rotational systems. These players often focus on specific clinical advantages, such as improved visualization, targeted plaque removal, or simplified system design, to gain traction in specialized procedure segments.

Atherectomy Devices Market Companies

A few of the prominent players operating in the atherectomy devices industry include:

• Abbott
• angiodynamics
• AVINGER
• Becton Dickinson and Company
• Boston Scientific
• Cardio Flow
• Medtronic
• MicroPort
• Nipro
• Philips
• Ra Medical Systems
• Rex Medical
   
• Abbott

Abbott holds a strong position in the market through its acquisition of Cardiovascular Systems, Inc. (CSI) and its established presence in vascular interventions. The company’s strength lies in its orbital atherectomy technology, which is widely used for treating calcified peripheral and coronary lesions. Abbott’s integrated cardiovascular portfolio, combined with its focus on innovation and clinical outcomes, enables efficient vessel preparation and supports its competitive positioning in minimally invasive vascular procedures.

• Medtronic

It has established a notable presence in the atherectomy devices market through its directional atherectomy systems and broad minimally invasive therapies portfolio. The company offers devices such as the HawkOne system, which enable targeted plaque removal while preserving vessel integrity. Medtronic focuses on clinical reliability, ease of use, and procedural efficiency, supported by its global distribution network and strong relationships with healthcare providers across cardiovascular care settings.

• Boston Scientific

Boston Scientific is a key player in the atherectomy devices market, supported by its comprehensive interventional cardiology portfolio and strong global reach. The company offers rotational atherectomy systems such as Jetstream, designed to treat complex and calcified lesions across peripheral applications. Boston Scientific emphasizes procedural versatility, safety features such as active aspiration, and integration with adjunctive therapies like drug‑coated balloons, making its solutions highly effective in real‑world vascular interventions.

The atherectomy devices market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2022 – 2035 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Orbital atherectomy devices
• Laser atherectomy devices
• Directional atherectomy devices
• Rotational atherectomy devices

Market, By Application

• Peripheral vascular applications
• Coronary applications

Market, By End Use

• Hospitals
• Ambulatory surgical centers
• Other end users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE